| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Denyes Nancy is a General Counsel at aTYR PHARMA INC. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $25K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | ATYR Atyr Pharma Inc | General Counsel | Sale+OE | 899 | $3.78 | $3,398.22 | -3.3% | -6.0% | -76.9% | |
| Jun 5, 2024 | ATYR Atyr Pharma Inc | General Counsel | Buy | 5,000 | $1.86 | $9,276.00 | +29.0% | -2.2% | +194.0% | |
| May 20, 2020 | ATYR Atyr Pharma Inc | General Counsel | Sale+OE | 322 | $3.62 | $1,165.64 | -10.5% | - | - | |
| May 17, 2019 | ATYR Atyr Pharma Inc | General Counsel | Sale+OE | 4,651 | $0.45 | $2,093.42 | -15.5% | - | - |